JP2016512501A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512501A5
JP2016512501A5 JP2016500869A JP2016500869A JP2016512501A5 JP 2016512501 A5 JP2016512501 A5 JP 2016512501A5 JP 2016500869 A JP2016500869 A JP 2016500869A JP 2016500869 A JP2016500869 A JP 2016500869A JP 2016512501 A5 JP2016512501 A5 JP 2016512501A5
Authority
JP
Japan
Prior art keywords
butoxy
tert
alkyl
acetic acid
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512501A (ja
JP6268656B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021867 external-priority patent/WO2014159076A1/en
Publication of JP2016512501A publication Critical patent/JP2016512501A/ja
Publication of JP2016512501A5 publication Critical patent/JP2016512501A5/ja
Application granted granted Critical
Publication of JP6268656B2 publication Critical patent/JP6268656B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500869A 2013-03-14 2014-03-07 ヒト免疫不全ウイルス複製の阻害剤 Expired - Fee Related JP6268656B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361781315P 2013-03-14 2013-03-14
US61/781,315 2013-03-14
PCT/US2014/021867 WO2014159076A1 (en) 2013-03-14 2014-03-07 Inhibitors of human immunodeficiency virus replication

Publications (3)

Publication Number Publication Date
JP2016512501A JP2016512501A (ja) 2016-04-28
JP2016512501A5 true JP2016512501A5 (enExample) 2017-03-09
JP6268656B2 JP6268656B2 (ja) 2018-01-31

Family

ID=50439486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500869A Expired - Fee Related JP6268656B2 (ja) 2013-03-14 2014-03-07 ヒト免疫不全ウイルス複製の阻害剤

Country Status (5)

Country Link
US (1) US9540393B2 (enExample)
EP (1) EP2970297A1 (enExample)
JP (1) JP6268656B2 (enExample)
CN (1) CN105008369B (enExample)
WO (1) WO2014159076A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3152211A1 (en) * 2014-02-12 2017-04-12 ViiV Healthcare UK (No.5) Limited Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
US9409922B2 (en) 2014-02-18 2016-08-09 Bristol-Myers Squibb Company Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
US9273067B2 (en) 2014-02-19 2016-03-01 Bristol-Myers Squibb Company Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
CN116005285B (zh) * 2022-12-26 2025-03-25 广东蒙泰高新纤维股份有限公司 一种抗紫外回收餐盒聚丙烯纤维的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939545B2 (en) 2006-05-16 2011-05-10 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
BRPI0714622A2 (pt) 2006-08-04 2013-04-30 Merz Pharma Gmbh & Co Kgaa pirazolopirimidinas substituÍdas, processo para sua preparaÇço e seu uso como medicamento
PT2220076E (pt) 2007-11-15 2012-04-26 Gilead Sciences Inc Inibidores da replicação do vírus da imunodeficiência humana
NZ585297A (en) 2007-11-15 2012-06-29 Gilead Sciences Inc Inhibitors of human immunodeficiency virus replication
BRPI0820307A2 (pt) 2007-11-16 2019-09-24 Boehringer Ingelheim Int inibidores de replicação do vírus da imunodeficiência humana
US8461180B2 (en) 2007-11-16 2013-06-11 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
US8353602B2 (en) 2007-11-23 2013-01-15 Koninklijke Philips Electronics N.V. Compartment
TW200942243A (en) * 2008-03-05 2009-10-16 Biocryst Pharm Inc Antiviral therapeutic agents
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
US8338441B2 (en) 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
ES2475970T3 (es) 2009-12-23 2014-07-11 Katholieke Universiteit Leuven Novedosos compuestos antivirales
PE20130385A1 (es) 2010-07-02 2013-03-30 Gilead Sciences Inc Derivados del acido naft-2-ilacetico para tratar el sida
PT2588455T (pt) 2010-07-02 2018-06-29 Gilead Sciences Inc Derivados de ácido 2-quinolinil-acético como compostos antivirais para vih
US8633200B2 (en) * 2010-09-08 2014-01-21 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
AU2011330850B2 (en) 2010-11-15 2016-01-28 Viiv Healthcare Uk Limited Inhibitors of HIV replication
WO2012065963A2 (en) 2010-11-15 2012-05-24 Katholieke Universiteit Leuven Novel antiviral compounds
AU2012257513B2 (en) * 2011-05-19 2017-05-11 Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Macrocyclic compounds as protein kinase inhibitors
US8791108B2 (en) * 2011-08-18 2014-07-29 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
US8906929B2 (en) * 2012-08-16 2014-12-09 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication

Similar Documents

Publication Publication Date Title
PH12021500049A1 (en) 2,3-dihydroquinazolin compounds as nav1.8 inhibitors
JP2016512558A5 (enExample)
JP2015524841A5 (enExample)
JP2016512507A5 (enExample)
JP2016516692A5 (enExample)
JP2013531029A5 (enExample)
HRP20241553T1 (hr) 4-(4-(4-(((2-(2,6-dioksopiperidin-3-il)-l-oksoizoindolin-4-il)oksi)metil)benzil)piperazin-l-il)-3-fluorobenzonitril kao antiproliferativni spoj
JP2016512511A5 (enExample)
JP2016506961A5 (enExample)
SI3024819T1 (en) Glyoxamide-substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis B
JP2016506962A5 (enExample)
PE20161218A1 (es) (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1
NZ708593A (en) Novel pyrazole derivative
JP2018522927A5 (enExample)
MX2020001717A (es) Inhibidores macrociclicos de mcl-1 y metodos de uso.
JP2020507589A5 (enExample)
UA115881C2 (uk) Алкоксипіразоли як активатори розчинної гуанілатциклази
EA201790088A1 (ru) Ингибиторы syk
JP2017526677A5 (enExample)
JP2017526748A5 (enExample)
IL257240A (en) History of 5– (n– benzyl tetrahydroisoquinoline – 6 – il) Pyridine – 3 – il Acetic acid as inhibitors of human immunodeficiency virus replication
MX341341B (es) Derivados de benzamida y su uso como inhibidores de proteina de choque termico 90 kda (hsp90).
GEP20237476B (en) N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors
JP2016512501A5 (enExample)
RU2017107715A (ru) Производные имидазо[1,2-a]пиридина для применения в качестве ингибиторов репликации вируса иммунодефицита человека